about
Tau and tauopathiesMaintenance of synaptic stability requires calcium-independent phospholipase A₂ activityAssigning backbone NMR resonances for full length tau isoforms: efficient compromise between manual assignments and reduced dimensionalityFrontotemporal Dementia.Proteomics analysis of the neurodegeneration in the brain of tau transgenic mice.Tau potentiates nerve growth factor-induced mitogen-activated protein kinase signaling and neurite initiation without a requirement for microtubule binding.Physiological requirement for both SH2 domains for phospholipase C-gamma1 function and interaction with platelet-derived growth factor receptorsIs tau a suitable therapeutical target in tauopathies?Dysregulation of protein phosphorylation/dephosphorylation in Alzheimer's disease: a therapeutic targetStable expression in Chinese hamster ovary cells of mutated tau genes causing frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)The many faces of tauPotential contribution of exosomes to the prion-like propagation of lesions in Alzheimer's disease.Connecting cell-cycle activation to neurodegeneration in Drosophila.The role of tau in neurodegenerationFunctional implications of glycogen synthase kinase-3-mediated tau phosphorylationP70 S6 kinase mediates tau phosphorylation and synthesis.Blockade of NR2A-containing NMDA receptors induces Tau phosphorylation in rat hippocampal slices.Yeast as a model system to study tau biology.Derailed intraneuronal signalling drives pathogenesis in sporadic and familial Alzheimer's disease.Haplotype-specific MAPT exon 3 expression regulated by common intronic polymorphisms associated with Parkinsonian disorders.Hyperosmotic stress-induced apoptosis and tau phosphorylation in human neuroblastoma cells.Tau and HMW tau phosphorylation and compartmentalization in apoptotic neuronal PC12 cells.Role of N-terminal tau domain integrity on the survival of cerebellar granule neurons.The microtubule binding of Tau and high molecular weight Tau in apoptotic PC12 cells is impaired because of altered phosphorylation.Proximity Ligation Assay: A Tool to Study Endogenous Interactions Between Tau and Its Neuronal Partners.
P2860
Q27027415-7CADD213-DD6D-485D-AF07-19C39C2C0E94Q27027705-EF5F4B01-C117-4339-A1D2-3C13618017CEQ28482414-96D129A0-85AF-4DC1-A095-A68173485658Q30234793-72924782-6B4C-4DE8-AF21-B1F2FDCA236BQ30835951-40005C47-3BA3-4C47-8A81-3A8ADB5A3760Q33911246-DD2363DC-0119-4203-82B5-7B8AA56A169DQ33958685-33072BBA-BE8F-4A7F-BFBB-ED81FE4B1A1EQ34878802-7C333836-C3AF-406E-960C-0EA62605C91EQ35016882-FBEF3088-E594-40BD-8E6B-5AD12A58DB40Q35787173-5758DD4A-9E76-4721-A3A6-8E80A9753F52Q35870359-010A454D-6F74-431F-8C3B-556407846B3AQ36076343-04957941-92B8-40C4-AF86-0F49AA576BBBQ36671551-DCBD194C-B8B0-4D4B-877F-CB225236BFBFQ37145919-197D9975-6595-49E1-976B-ADA3884F38A5Q37903257-AF8CCABD-5006-4197-BD68-484B6C6BEE41Q40338655-2566BBC2-F498-4226-A7E8-60CD3C0206ABQ40700702-1A7D7C67-22C5-4C94-A8D0-8B8680093553Q42729005-44400EAB-A5E8-43ED-A0A4-75932903851DQ42872730-7A8F9AE5-DF75-48B4-A9D8-1B255452FD97Q43287320-FDCABC1B-1DC2-4173-B23F-9CFE679EF041Q43732934-748F34BC-ADF1-4988-B152-6C26D5BB3203Q43760336-5D689077-D55C-49F8-9FD3-0438FF380204Q44654504-25C9081D-5EB5-4A2B-B732-12747A557366Q47252107-115F82E8-25FA-4D03-BD71-E4E95C557E22Q51263429-86D709F5-14FF-493A-8054-2E71E68BF761
P2860
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Tau complexes with phospholipase C-gamma in situ.
@en
type
label
Tau complexes with phospholipase C-gamma in situ.
@en
prefLabel
Tau complexes with phospholipase C-gamma in situ.
@en
P1433
P1476
Tau complexes with phospholipase C-gamma in situ.
@en
P2093
Jenkins SM
Johnson GV
P356
10.1097/00001756-199801050-00014
P577
1998-01-01T00:00:00Z